Kiora Pharmaceuticals, Inc. (KPRX) Financials

KPRX Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 15.9 million 7.8 million
2023-06-30 19.9 million 6.2 million
2023-03-31 16.5 million 6.4 million
2022-12-31 18.7 million 7.3 million

KPRX Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 -2.5 million 264864
2023-06-30 -1.4 million 171795
2023-03-31 -3.1 million 135941
2022-12-31 -2.1 million 45122

KPRX Net Income

No data available :(

KPRX Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 5.4 million - 18725
2023-06-30 8.0 million - 39009
2023-03-31 3.4 million - 73289
2022-12-31 6.0 million - 105782

KPRX Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 7.1 million
2023-06-30 3.3 million
2023-03-31 1.9 million
2022-12-31 732303

KPRX Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 - 1.1 million 1.4 million -
2023-06-30 - 1.4 million 1.1 million -
2023-03-31 - 438283 1.3 million -
2022-12-31 - 841617 2.8 million -

KPRX Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 - 42382
2023-06-30 - 56698
2023-03-31 - 42856
2022-12-31 - 10285

KPRX

Price: $0.51

52 week price:
0.46
5.25

Earnings Per Share: -2.69 USD

P/E Ratio: 0.85

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Volume: 47600

Market Capitalization: 15.1 million

Links: